STOCK TITAN

Cryoport (CYRX) director Linda Baddour receives new stock and option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cryoport, Inc. director Linda Baddour received new equity compensation on June 5, 2026. She was granted 10,350 restricted stock rights that vest in full on June 5, 2027 and will convert into 10,350 shares of common stock on a one-for-one basis at that time.

She also received options to buy 16,077 shares of common stock at an exercise price of $15.70 per share. One-twelfth of these options vest on the 5th of each month for twelve months beginning July 5, 2026, and they expire on June 5, 2033. Following the restricted stock grant, she directly holds 68,099 common shares.

Positive

  • None.

Negative

  • None.
Insider BADDOUR LINDA
Role null
Type Security Shares Price Value
Grant/Award Option (Right to Buy Common Stock) 16,077 $0.00 --
Grant/Award Common Stock 10,350 $0.00 --
Holdings After Transaction: Option (Right to Buy Common Stock) — 16,077 shares (Direct, null); Common Stock — 68,099 shares (Direct, null)
Footnotes (1)
  1. Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis. 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Restricted stock rights granted 10,350 rights Grant of restricted stock rights on June 5, 2026
RSR vesting date June 5, 2027 Restricted stock rights vest in full on this date
Options granted 16,077 options Option grant on June 5, 2026
Option exercise price <money>$15.70</money> per share Strike price for 16,077 options
Option vesting schedule 1/12 monthly Vests monthly on the 5th from July 5, 2026 for 12 months
Option expiration date June 5, 2033 Expiration of granted options
Shares held after grant 68,099 shares Common stock directly held following restricted stock grant
restricted stock rights financial
"Reflects grant of restricted stock rights that vest in full on June 5, 2027"
Restricted stock rights are ownership claims in company shares that come with limits on when or how they can be sold or transferred, often tied to time-based or performance conditions. For investors, these rights matter because they affect when insiders truly own or can monetize shares — influencing future share supply, executive incentives, and potential stock price pressure much like a savings account that only becomes withdrawable after meeting set conditions.
Option (Right to Buy Common Stock) financial
"security_title: Option (Right to Buy Common Stock)"
exercise price financial
"conversion_or_exercise_price: "15.7000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"1/12th of the options vest on the 5th of the month"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: "2033-06-05T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BADDOUR LINDA

(Last)(First)(Middle)
C/O CRYOPORT INC.
112 WESTWOOD PLACE, SUITE 350

(Street)
BRENTWOOD TENNESSEE 37027

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)06/05/2026A10,350A$0(1)68,099D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (Right to Buy Common Stock)$15.706/05/2026A16,077 (2)06/05/2033Common Stock16,077$016,077D
Explanation of Responses:
1. Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
2. 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
/s/ Linda Baddour06/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Cryoport (CYRX) director Linda Baddour receive in this Form 4 filing?

Linda Baddour received new equity compensation consisting of 10,350 restricted stock rights and options for 16,077 shares. The restricted stock vests in 2027, while the options have a $15.70 strike price and vest monthly starting in July 2026.

When do Linda Baddour’s restricted stock rights in Cryoport (CYRX) vest?

The 10,350 restricted stock rights vest in full on June 5, 2027. Upon vesting, they automatically convert into 10,350 shares of Cryoport common stock on a one-for-one basis, increasing her directly held share count if none are transferred.

What are the key terms of Linda Baddour’s Cryoport (CYRX) stock options?

She received options on 16,077 shares of Cryoport common stock with a $15.70 exercise price. One-twelfth of the options vest monthly on the 5th from July 5, 2026 for twelve months, and the options expire on June 5, 2033.

How many Cryoport (CYRX) shares does Linda Baddour hold after these grants?

After the June 5, 2026 restricted stock grant, Linda Baddour directly holds 68,099 shares of Cryoport common stock. This figure reflects her non-derivative common stock position reported following the award in the Form 4 filing.

Are Linda Baddour’s Cryoport (CYRX) equity awards immediate purchases or long-term incentives?

These awards are long-term incentives rather than immediate market purchases. The restricted stock rights vest in 2027, and the options vest monthly over one year starting July 2026 with a $15.70 strike price and a June 2033 expiration date.